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Abstract A synthetic peptide (23 residues) that includes the
antibacterial and lipopolysaccharide-binding regions of human
lactoferricin, an antimicrobial sequence of lactoferrin, was used
to study its action on cytoplasmic membrane of Escherichia coli
0111 and E. coli phospholipid vesicles. The peptide caused a
depolarization of the bacterial cytoplasmic membrane, loss of the
pH gradient, and a bactericidal effect on E. coli. Similarly, the
binding of the peptide to liposomes dissipated previously created
transmembrane electrical and pH gradients. The dramatic
consequences of the transmembrane ion flux during the peptide
exposure indicate that the adverse effect on bacterial cells occurs
at the bacterial inner membrane.
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1. Introduction
The antimicrobial active N-terminal peptides derived from
acid-pepsin hydrolysis of human lactoferrin (lactoferricin H)
and bovine lactoferrin (lactoferricin B) and many synthetic
peptides derived from them are promising candidates of ther-
apeutic and industrial value due to their broad spectrum of
antimicrobial activities. These peptides present an enhanced
activity against a wider range of microorganisms than the
native lactoferrin [1^4]. Lactoferricin H corresponds to amino
acid residues 1^47 at the N-terminus of human lactoferrin,
and includes the antimicrobial sequence (residues 20^37) and
the amino acids (residues 28^34) involved in the high-a⁄nity
binding of the whole protein to lipopolysaccharides of Escher-
ichia coli [1,5].
The possibility to use antimicrobial peptides as a therapeut-
ical alternative due to the increase of the bacterial resistance
to the classical antibiotics requires a detailed knowledge of the
mechanism of action of each of these peptides. However, de-
spite the fact that the mode of action of di¡erent classes of
natural cationic antimicrobial peptides has been reported,
studies including synthetic peptides are scarce [6].
Previous studies about the mechanism of action of lactofer-
ricin and other derived peptides showed the ability of these
peptides to bind to lipopolysaccharides of E. coli, followed by
damage and permeability alterations of the bacterial outer
membrane [3,7,8]. However, the complete mechanism of the
antimicrobial action of the lactoferricin and derived peptides
remains unclear.
In the present work we have investigated the ability of a
lactoferrin H-derived synthetic peptide (Lfpep), which shows
antimicrobial and antiprotozoal properties [9], to interact with
bacterial inner membrane as well as phospholipid vesicles. The
e¡ects of Lfpep on the electrical and chemical proton gra-
dients on E. coli cells were studied. In a similar way, peptide
binding to liposomes, changes in transmembrane electrical
potential, pH gradient, and permeability of E. coli phospho-
lipid vesicles were also assayed.
2. Materials and methods
2.1. Materials
Materials were obtained from the following sources: The N-termi-
nal antimicrobial peptide of human lactoferrin (residues 17^39) was
synthesized by Chiron Mimotopes Pty. Ltd. (Clayton, Australia) with
the following sequence: NH2-TKCFQWQRNMRKVRGPPVSCIKR-
COOH. Purity of the peptide was demonstrated by reverse-phase
high-performance liquid chromatography (Chiron Mimotopes Pty.).
[14C]-acetic acid, [14C]-methylinulin, tritiated water, and [3H]TPP
were obtained from Amersham Corp. (Buckinghamshire, UK). Phos-
pholipids of E. coli were obtained from Avanti Polar Lipids, Inc.
(Birmingham, AL, USA). ANTS, diS-C3-(5), DPX, and pyranine
were purchased from Molecular Probes Europe BV (Leiden, The
Netherlands). Nigericin and valinomycin were supplied by Sigma
Chemicals, Co., USA.
2.2. Determination of membrane potential (v8) and vpH in E. coli
The transmembrane electrical potential (v8) and vpH of glucose-
energized cells were estimated from the transmembrane equilibrium
distribution of the lipophilic cation [3H]TPP and [14C]-acetic acid,
respectively [10]. Bacterial suspensions of E. coli 0111 ATCC 33780
(0.5 to 1 mg dry weight per ml) were centrifuged, washed twice, and
suspended in 10 ml of 10 mM potassium phosphate bu¡er (pH 7.0)
containing 150 mM glucose. To determine the transmembrane elec-
trical potential, 0.5 WCi/ml of [3H]TPP were added to 1 ml aliquots
and incubated for 5 min. Samples were taken before the peptide
addition as well as 5 and 15 min later. These samples were centrifu-
gated (8000Ug, 1 min) and aliquots from the supernatant as well as
the pellet were removed and the radioactivity was determined using a
liquid scintillation counter [11]. [3H]TPP uptake was corrected for
non-speci¢c binding as described [12]. Nernst equation was used to
calculate the membrane electrical potential [10]. Internal volume of E.
coli cells was measured using the non-permeant hydroxy [14C]-meth-
ylinulin (1 WCi/ml) and tritiated water (2 WCi/ml) as described [12].
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The vpH changes across the cytoplasmic membrane were deter-
mined in a similar way from the distribution of [14C]-acetic acid
(0.1 WCi/ml), which was added to cell suspensions and the mixture
incubated for 5 min at 25‡C. The E. coli internal pH was calculated as
described [10] using the equation:
pHin  log AinAout10
pKa  10pHout 310pKa
 
where Ain and Aout are the internal and external acetic acid concen-
tration, respectively.
2.3. Antibacterial assays
A standard microdilution technique [13] was used to determine the
minimal inhibitory concentration (MIC) of the Lfpep for E. coli 0111.
Assays were performed in sterile 96-well microtiter plates by using 1%
Bacto peptone (Difco) as growth medium. The peptide was serially
diluted to give concentrations between 0.8 WM and 180 WM in a ¢nal
volume of 100 Wl. The plates were incubated at 37‡C for 24 h. The
MIC was taken as the lowest peptide concentration at which observ-
able growth was inhibited. Cellular viability at visible growth inhib-
itory concentrations was assessed by serial dilution and drop counting
on Nutrient broth (Difco).
2.4. Preparation of liposomes
Total lipids from E. coli were mixed in chloroform:methanol (9:1,
vol/vol) and extensively evaporated. For binding and electrical poten-
tial assays, the lipid ¢lm was suspended by vortex mixing in a 50 mM
potassium phosphate bu¡er (pH 6.0) to obtain a ¢nal lipid concen-
tration of 20 mg/ml. The suspension was sonicated in an ice bath,
using a titanium tip ultrasonicator to obtain small unilamellar vesicles
(SUVs) as previously described [14]. Titanium debris were removed by
centrifugation. For vpH assays pyranine-containing SUVs were pre-
pared using a pyranine bu¡er solution (20 mM potassium phosphate,
pH 6.0; 100 mM potassium acetate) including 100 WM pyranine,
which was added to the dried lipid ¢lm before sonication. Non-encap-
sulated £uorescent probe was separated from the vesicle suspension
through a Sephadex G-50 gel ¢ltration column (Pharmacia, Uppsala,
Sweden) of 25U0.5 cm and eluted with bu¡er 20 mM potassium
phosphate (pH 6.0) containing 100 mM K-PIPES. For assays of
vesicle leakage, large unilamellar vesicles (LUVs) were prepared by
the extrusion method [15] using polycarbonate ¢lters with a pore size
of 100 nm (Nucleopore, Pleasanton, CA, USA). These vesicles con-
tained 12.5 mM ANTS, 45 mM DPX, and 20 mM Tris-HCl (pH 7.4).
When required, strictly isotonic conditions were ensured by checking
the osmotic pressure of intra- and extravesicular solutions in an Os-
momat 30 osmometer (Gonotec, Berlin, Germany). Phospholipid con-
centrations were determined by inorganic phosphorus analysis [16].
2.5. Fluorescence measurements
Fluorescence measurements were made using a Perkin-Elmer LS-50
spectro£uorometer. Binding of the peptide to vesicles was monitored
through changes in the intrinsic tryptophan £uorescence of the pep-
tide, which includes a single tryptophan (Trp-22). A ¢xed amount of
peptide (10 WM) was incubated overnight with LUVs composed of
phospholipids from E. coli at di¡erent phospholipid/peptide (L:P)
molar ratios at room temperature. Fluorescence spectra were recorded
using 5 mm path quartz cuvettes with excitation at 280 nm and emis-
sion from 300 to 400 nm, and slit widths of 2.5 nm. The spectra were
corrected for light scattering by subtracting the corresponding blank
spectra without the peptide [17].
In the quenching experiments, the peptide was added to a SUVs
suspension (0.2 mg/ml, ¢nal concentration) in 50 mM potassium phos-
phate bu¡er (pH 6.0). No corrections were made for changes in os-
molarity, as little change in 90‡ light scattering indicated little change
in vesicle structure. Small aliquots of the stock solutions of quenchers
(8 M acrylamide; 5 M potassium iodide) were added to vesicle sus-
pensions. Fluorescence intensity was measured for potassium iodide
(KI) or acrylamide after the signal had stabilized during 30 s. The
samples containing KI or acrylamide were excited at 280 nm and 295
nm, respectively. The emission wavelength was recorded in a range
from 310 to 380 nm. Results were ¢tted by linear regression using the
program Statistica (Statsoft, Inc., USA) to the Stern-Volmer equation
(Fo/F = 1+KsvWQ), where F and Fo are the £uorescence intensities with
and without quencher, Ksv is the Stern-Volmer constant, and Q is the
quencher concentration. Contributions of static quenching were gen-
erally unimportant below approximately 80^100 mM acrylamide as
determined by plotting (Fo/F31)/Q versus Q. Lack of upward curva-
ture of plots below 80^100 mM acrylamide supported this assumption
[18,19].
2.6. Monitoring of transmembrane potential (v8) and vpH in
liposomes
The reaction mixture (1 ml) contained 100-fold diluted liposomes in
a 50 mM sodium phosphate bu¡er (pH 6.0) and 1 WM of the £uo-
rescent potential-sensitive dye diS-C3-(5). A transmembrane K-dif-
fusion potential (negative inside) was generated in the phospholipid
vesicles by addition of valinomycin (1 WM), a potassium ionophore
[20]. Changes of transmembrane potential in the liposomes were con-
tinuously monitored by the £uorescence quenching of diS-C3-(5) using
a spectro£uorometer. Experiments were performed at 25‡C at a wave-
length of excitation and emission of 616 nm and 676 nm, respectively.
Changes in the internal pH of liposomes was monitored from the
£uorescence of pyranine entrapped within the liposomes [20]. Lipo-
somes were diluted 100-fold in 20 mM potassium phosphate (pH 6.0)
containing 100 mM K-PIPES for the generation of a pH gradient.
The assays were carried out at 25‡C at a wavelength of excitation and
emission of 450 nm and 508 nm, respectively.
3. Results
3.1. E¡ect of Lfpep on membrane potential (v8) and vpH in
E. coli
Glucose-energized cells of E. coli 0111 were used to inves-
tigate the Lfpep e¡ects on v8 and vpH of E. coli 0111. De-
termination of v8 was performed using the lipophilic cation
[3H]TPP as described in Section 2. The v8 value in the
control assays was estimated at 3110 mV. The addition of
di¡erent concentrations of the peptide (0.2, 2, 10, 20, 45, 90,
180 WM) resulted in a immediate releasing of the previously
accumulated [3H]TPP at concentrations v20 WM, indicating
the dissipation of v8. In control experiments, the addition of
n-butanol (7%) to the cellular suspension also induced a com-
plete dissipation of the v8 of E. coli.
In a similar way, the vpH was determined by the distribu-
tion of [14C]-acetic acid as described in Section 2. The internal
pH of E. coli was estimated in 8.3 units at a external pH of
7.0. The Lfpep addition to the cells caused a total loss of
vpH, after 15 min, when the concentrations assayed were
v90 WM.
Fig. 1. Changes in tryptophan £uorescence of Lfpep bound to E.
coli phospholipid liposomes. A ¢xed concentration of Lfpep was
mixed with various amounts of liposomes to obtain a phospholip-
id:peptide ratio (mol:mol) of 2.5, 5, 10, 25, 50, 0 (from top to bot-
tom).
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3.2. Antibacterial assays
The ability of the Lfpep to inhibit the growth of E. coli was
determined using a broth microdilution assay. The number of
cells present in each well was adjusted to obtain a similar
number of CFU/ml as in transmembrane electrochemical gra-
dient determination assays. Results showed that the minimum
concentration of the Lfpep inhibiting growth (MIC) was 90
WM. This concentration was bactericidal and no growth was
observed on counting plates.
3.3. Intrinsic tryptophan £uorescence studies
Intrinsic tryptophan £uorescence changes derived from
binding of Lfpep to liposomes were estimated. A ¢xed con-
centration (10 WM) of the peptide was mixed with various
amounts of LUVs and the £uorescence spectra in the equili-
brium state were measured. The addition of increasing
amounts of vesicles caused a blue shift in the maximum wave-
length (Fig. 1).
Changes in the £uorescence quenching of the Trp residue
microenvironment were investigated using iodine, as ionic
quencher, and acrylamide as an uncharged quencher. Fig. 2
shows Stern-Volmer plots for intrinsic tryptophan £uores-
cence quenching by both quenchers in absence and presence
of liposomes. In absence of liposomes, iodine quenching was
minimal with a Stern-Volmer quenching constant (Ksv) of 0.57
M31 and no signi¢cant changes were observed when lipo-
somes were added (Ksv = 0.6 M31). Intrinsic tryptophan £uo-
rescence was quenched more e⁄ciently by acrylamide than
iodine in absence of liposomes (Ksv = 3.6 M31), but the Trp-
22 was more accessible to acrylamide, with a quenching con-
stant of 11.3 M31, in presence of liposomes.
3.4. E¡ect of Lfpep on v8 and vpH in liposomes
The Lfpep e¡ect on the valinomycin-induced transmem-
brane potential in phospholipid vesicles of E. coli was deter-
mined using diS-C3-(5), a membrane potential-sensitive probe.
The addition of the di¡erent concentrations (0.1, 0.2, 0.4, 0.8,
4, 8 WM) of the peptide to the valinomycin-hyperpolarized
liposomes completely reversed the £uorescent quenching,
and the minimal concentration of Lfpep necessary to achieve
the potential loss was 0.2 WM (Fig. 3). However, no changes
in the £uorescence quenching were detected when the peptide
was added to the liposomal suspension before the addition of
the ionophore (data not shown).
The e¡ect of Lfpep on internal pH of E. coli phospholipid
liposomes containing pyranine was investigated. An arti¢cial
pH gradient was generated as described in Section 2, and the
changes experimented by the addition of peptide were moni-
tored measuring the £uorescence of the entrapped £uorescent
probe. The initial vpH was estimated in 1.2 units using niger-
icin (1 WM), in previous assays. Di¡erent peptide concentra-
tions from 0.1 to 8 WM were assayed, resulting in 0.2 WM
minimal concentration that induced a total dissipation of
the previously generated pH gradient (Fig. 4).
3.5. Vesicle leakage studies
The ANTS/DPX complex leakage induced by Lfpep (1 and
20 WM) from liposomes composed of total lipids from E. coli
was monitored. The peptide was unable to induce leakage of
the £uorescent probes at the concentrations tested (Fig. 5).
Fig. 2. Acrylamide and iodine quenching of Lfpep tryptophan.
Acrylamide quenching in absence (F) and presence (E) of liposomes.
Iodine quenching in absence (b) and presence (a) of liposomes.
Fig. 3. E¡ect of Lfpep on the ANTS/DPX leakage from E. coli
liposomes. Lfpep at di¡erent concentrations (A) 1 WM, or (B) 20
WM, and Triton X-100 (TX-100) were added at indicated times.
Leakage is marked by an increase in £uorescence intensity.
Fig. 4. E¡ect of Lfpep on the diS-C3-(5) £uorescence quenching in-
duced by valinomycin in E. coli phospholipid liposomes. Valinomy-
cin (Val; 1 WM) and Lfpep (0.2 WM) were added at indicated times.
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Nevertheless, 100% release was achieved when 5 Wl of 10%
(w/v) Triton X-100 was added at the end of the assay as a
probe-releasing control.
4. Discussion
Lactoferricin is a single antimicrobial peptide generated by
the lactoferrin acid-pepsin hydrolysis, an iron-binding protein
found in several body £uids of mammals and mainly secreted
by polymorphonuclear neutrophils. Disruption of the bacteri-
al outer membrane mediated by a derived peptide has been
reported [8], however the complete antimicrobial mechanism
of action of the lactoferricin and derived peptides is unknown.
In an attempt to understand the antimicrobial mechanism
of a lactoferricin-derived peptide (Lfpep) we investigated its
ability to disrupt the E. coli inner membrane permeability.
Energy transduction is one of the principal functions of the
cytoplasmic membrane, which involves the generation of a
proton-motive force (vp). The vp is composed of an electrical
gradient (v8) and a proton gradient (vpH). In general,
changes in the inner membrane integrity induce a loss of the
v8 and/or vpH a¡ecting to vital processes of bacteria, such as
the Na or K gradients across the cytoplasmic membrane,
ATP synthesis, or solute transport [21^24]. We performed
assays to determine the e¡ects of Lfpep on the transmembrane
potential and pH gradient of E. coli 0111. Determination of
the v8 indicated that the peptide was able to induce a drastic
and quick loss of the bacterial transmembrane electrical po-
tential. In addition, Lfpep was also able to induce the loss of
the vpH as was determined by the cytoplasmic accumulation
of the [14C]-acetic acid.
The observed e¡ects on E. coli cells were further investi-
gated using E. coli phospholipid liposomes. Binding of Lfpep
to liposomes was monitored measuring the intrinsic £uores-
cence of the single Trp residue of the peptide. Study of in-
trinsic £uorescence provides insights into the environment,
structure and dynamics of the £uorophores [25]. In presence
of liposomes, the Trp-emission wavelength was shortened
(blue shift) suggesting a decrease of the environment polarity
associated with the binding of the peptide to the membranes.
Peptide binding was also analyzed performing quenching ex-
periments using the iodine and acrylamide quenchers in pres-
ence or absence of liposomes. Changes in the exposure of
tryptophan can be determined using low molecular weight
quenching agents that are able to decrease the £uorescence
intensity due to a direct interaction with the excited indole
group. These variations can be produced by binding to other
molecules or by peptide conformational changes [18]. In our
assays, iodine was not an e¡ective quencher, and no signi¢-
cant modi¢cations were observed after the liposome addition.
This could be due to the fact that iodine is an ionic quencher
and therefore charged and very hydrated, what makes it able
to quench only surface tryptophan residues, and sensitive to
electrostatic e¡ects that may in£uence its quenching action. In
contrast, acrylamide is an uncharged molecule and conse-
quently its quenching e¡ect is very sensitive to the tryptophan
exposure [19]. Acrylamide was a more e⁄cient quencher than
iodine, and its e¡ect was greatly enhanced after the peptide
binding to liposomes, indicating an increased exposure of the
tryptophan to the quencher. Quenching assays suggest that
Lfpep is able to bind to liposomes. Interestingly, this peptide
is very basic (pI = 12) with a high positive charge (+7) and
forms an amphipathic alpha-helix in the native protein sur-
face. That features are very common in peptides showing
antibacterial activity independently of the sequence homology
[6,26]. The increase in the exposure of the Trp in presence of
liposomes could be re£ecting changes in the bound peptide
structure.
The consequences of this interaction with respect to the
previous generated v8 and vpH in liposomes were monitored
using the £uorescent probes diS-C3-(5) and pyranine, respec-
tively. The Lfpep was able to induce a total dissipation of the
generated valinomycin-dependent electrical potential. How-
ever, when the Lfpep was added before the ionophore the
generation of the electrical potential was not observed. On
the other hand, the peptide was able to dissipate a previously
generated pH gradient in liposomes. All the above results
show the ability of the peptide to permeate di¡erent ions.
To determine if other high molecular weight agents could be
permeated, the leakage of entrapped ANTS/DPX from the
vesicles was determined. At high concentrations (i.e. inside
the vesicles) ANTS and DPX form a low-£uorescence com-
plex, the breakdown of the vesicle membrane releases both
molecules resulting in the complex decomposition and a
high ANTS £uorescence [27]. In our case, Lfpep binding did
not cause enough membrane disruption to induce the leakage
of encapsulated ANTS/DPX, even though the peptide concen-
trations used in this assay (1 and 20 WM) were 5 and 100 times
greater than the dose needed to induce membrane depolariza-
tion (0.2 WM). These results support the ability of Lfpep to
permeate ions, excluding molecules of high molecular weight,
without a generalized membrane disintegration.
The overall result supports the ability of Lfpep to interact
with the cytoplasmic membrane of E. coli and liposomes pro-
ducing a non-speci¢c ion permeation, and inducing a v8 dis-
sipation and loss of the vpH in both models. The dissipation
of both v8 and vpH could impair some vital cell membrane
functions, such as the production of ATP, causing the cellular
death. This suggestion could explain the bactericidal e¡ect of
Lfpep on E. coli, and is supported by the similar peptide
Fig. 5. E¡ect of Lfpep on vpH in E. coli phospholipid liposomes.
Lfpep (0.2 WM) was added at the indicated time. Changes of the
vpH were monitored by the £uorescence changes of the liposome
entrapped pyranine, used as pH indicator.
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concentration necessary to induce the loss of the vpH and the
inhibition of the cellular growth (MIC). Despite the fact that
Lfpep includes the antimicrobial homologous sequence
present in lactoferrin, the results obtained here can not be
extrapolated to explain the antimicrobial action of the whole
molecule of lactoferrin, which exerts only a bacteriostatic ef-
fect on E. coli [7].
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